^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    INO-3106

    i
    Associations
    News

    Trials

    Company:
    Inovio
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies (NCT02241369)
    Phase 1
    Inovio Pharmaceuticals
    Completed
    Last update posted :
    11/16/2018
    Initiation :
    05/01/2014
    Primary completion :
    09/01/2018
    Completion :
    09/01/2018
    IFNG
    |
    rocakinogene sifuplasmid (INO-9012) • INO-3106